DataMeds AI, Inc. (MEDS)
1.16
-0.06
(-4.92%)
USD |
NASDAQ |
Nov 06, 10:29
DataMeds AI Debt to Equity Ratio : -1.681 for June 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.681 |
| March 31, 2026 | -1.920 |
| December 31, 2025 | -1.990 |
| September 30, 2025 | 3.865 |
| June 30, 2025 | 27.47 |
| March 31, 2025 | 5.748 |
| Date | Value |
|---|---|
| December 31, 2024 | 3.728 |
| September 30, 2024 | 2.211 |
| June 30, 2024 | -0.6429 |
| March 31, 2024 | -0.2018 |
| December 31, 2023 | -0.1207 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Exlites Holdings International, Inc. | 0.00 |
| Xcelerate, Inc. | -0.8535 |
| PD-Rx Pharmaceuticals, Inc. | -- |
| Acro Biomedical Co. Ltd. | -0.8665 |
| Vivos Therapeutics, Inc. | -3.278 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 32.76M |
| Total Liabilities (Quarterly) | 52.26M |
| Shareholders Equity (Quarterly) | -19.50M |
| Current Ratio | 0.1429 |
| Net Debt Paydown Yield | -16.03% |